Cancer-associated fibroblasts produce matrix-bound vesicles that influence endothelial cell function.
Alice SantiEmily J KayLisa J NeilsonLynn McGarrySergio LillaMargaret MullinNikki R PaulFrédéric FercoqGrigorios KoulourasGiovanny Rodriguez BlancoDimitris AthineosSusan MasonMark HughesGemma ThomsonYann KiefferColin NixonKaren BlythFatima Mechta-GrigoriouLeo M CarlinSara R ZanivanPublished in: Science signaling (2024)
Intercellular communication between different cell types in solid tumors contributes to tumor growth and metastatic dissemination. The secretome of cancer-associated fibroblasts (CAFs) plays major roles in these processes. Using human mammary CAFs, we showed that CAFs with a myofibroblast phenotype released extracellular vesicles that transferred proteins to endothelial cells (ECs) that affected their interaction with immune cells. Mass spectrometry-based proteomics identified proteins transferred from CAFs to ECs, which included plasma membrane receptors. Using THY1 as an example of a transferred plasma membrane-bound protein, we showed that CAF-derived proteins increased the adhesion of a monocyte cell line to ECs. CAFs produced high amounts of matrix-bound EVs, which were the primary vehicles of protein transfer. Hence, our work paves the way for future studies that investigate how CAF-derived matrix-bound EVs influence tumor pathology by regulating the function of neighboring cancer, stromal, and immune cells.
Keyphrases
- endothelial cells
- mass spectrometry
- high glucose
- vascular endothelial growth factor
- protein protein
- small cell lung cancer
- liquid chromatography
- papillary thyroid
- binding protein
- single cell
- stem cells
- dendritic cells
- transforming growth factor
- high resolution
- high performance liquid chromatography
- biofilm formation
- cystic fibrosis
- induced pluripotent stem cells
- pulmonary fibrosis